HUSSAIN IQBAL J

Insider profile

Performance

Overall performance
1.5

Performance over holding periods
1.5
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 1% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
HUSSAIN IQBAL J's trades of Centessa Pharmaceuticals PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-03 2026-02-02 S Sale
32,734 -18.0%
197.34
US$3,809,274
32,734 -18.0% 197.34 US$3,809,274
2026-02-03 2026-02-02 S Sale
13,023 -36.9%
440.92
US$2,923,297
13,023 -36.9% 440.92 US$2,923,297
2026-02-03 2026-01-30 S Sale
97,913 -39.6%
383.65
US$3,921,569
97,913 -39.6% 383.65 US$3,921,569
2026-01-30 2026-01-30 PrS Proposed sale
39,961
25.50
US$1,019,005
39,961 25.50 US$1,019,005
2025-11-18 2025-11-17 PlS Planned sale
6,000 -5.4%
27.64
US$165,835
6,000 -5.4% 27.64 US$165,835
2025-11-17 2025-11-17 PrS Proposed sale
6,000
27.74
US$166,440
6,000 27.74 US$166,440
2025-10-16 2025-10-15 PlS Planned sale
6,000 -5.4%
22.41
US$134,439
6,000 -5.4% 22.41 US$134,439
2025-10-15 2025-10-15 PrS Proposed sale
6,000
22.61
US$135,660
6,000 22.61 US$135,660
2025-09-15 2025-09-15 PrS Proposed sale
6,000
21.81
US$130,860
6,000 21.81 US$130,860
2025-09-15 2025-09-15 PlS Planned sale
6,000 -5.4%
21.85
US$131,101
6,000 -5.4% 21.85 US$131,101
2025-09-11 2025-09-10 PlS Planned sale
20,000 -16.0%
22.00
US$440,000
20,000 -16.0% 22.00 US$440,000
2025-09-10 2025-09-10 PrS Proposed sale
20,000
22.00
US$440,000
20,000 22.00 US$440,000
2025-09-11 2025-09-09 PlS Planned sale
20,000 -16.0%
20.01
US$400,102
20,000 -16.0% 20.01 US$400,102
2025-09-09 2025-09-09 PrS Proposed sale
20,000
20.01
US$400,102
20,000 20.01 US$400,102
2025-08-15 2025-08-15 PrS Proposed sale
6,000
17.23
US$103,380
6,000 17.23 US$103,380
2025-08-15 2025-08-15 PlS Planned sale
6,000 -5.4%
17.23
US$103,380
6,000 -5.4% 17.23 US$103,380
2025-07-17 2025-07-15 PlS Planned sale
6,000 -5.4%
14.93
US$89,567
6,000 -5.4% 14.93 US$89,567
2025-07-15 2025-07-15 PrS Proposed sale
6,000
14.93
US$89,567
6,000 14.93 US$89,567
2025-06-25 2025-06-24 PlS Planned sale
12,000 -10.2%
14.02
US$168,218
12,000 -10.2% 14.02 US$168,218
2025-06-24 2025-06-24 PrS Proposed sale
12,000
14.02
US$168,218
12,000 14.02 US$168,218
2025-05-02 2025-05-01 PlS Planned sale
311 -0.3%
14.00
US$4,354
311 -0.3% 14.00 US$4,354
2025-04-29 2025-04-28 PlS Planned sale
2,080 -1.9%
14.01
US$29,132
2,080 -1.9% 14.01 US$29,132
2025-04-28 2025-04-28 PrS Proposed sale
2,391
14.00
US$33,474
2,391 14.00 US$33,474
2025-04-29 2025-04-25 PlS Planned sale
3,609 -3.3%
14.00
US$50,526
3,609 -3.3% 14.00 US$50,526
2025-04-25 2025-04-25 PrS Proposed sale
3,609
14.00
US$50,526
3,609 14.00 US$50,526
2025-03-19 2025-03-17 PlS Planned sale
6,000 -5.4%
16.45
US$98,697
6,000 -5.4% 16.45 US$98,697
2025-03-17 2025-03-17 PrS Proposed sale
6,000
17.07
US$102,420
6,000 17.07 US$102,420
2025-02-19 2025-02-18 PlS Planned sale
1,388 -1.3%
17.05
US$23,669
1,388 -1.3% 17.05 US$23,669
2025-02-19 2025-02-18 PlS Planned sale
4,612 -4.1%
15.91
US$73,396
4,612 -4.1% 15.91 US$73,396
2025-02-18 2025-02-18 PrS Proposed sale
6,000
17.07
US$102,420
6,000 17.07 US$102,420
2025-01-17 2025-01-15 PlS Planned sale
6,000 -4.8%
15.29
US$91,740
6,000 -4.8% 15.29 US$91,740
2025-01-15 2025-01-15 PrS Proposed sale
6,000
15.12
US$90,720
6,000 15.12 US$90,720
2024-12-17 2024-12-16 PlS Planned sale
77,705 -38.2%
16.39
US$1,273,756
77,705 -38.2% 16.39 US$1,273,756
2024-12-16 2024-12-16 PrS Proposed sale
77,705
16.57
US$1,287,572
77,705 16.57 US$1,287,572
2022-10-04 2022-10-03 S Sale
4,563 -2.9%
3.95
US$18,024
4,563 -2.9% 3.95 US$18,024
2022-10-04 2022-09-30 S Sale
3,725 -2.3%
4.07
US$15,151
3,725 -2.3% 4.07 US$15,151